Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 1;184(5):699–709. doi: 10.1530/EJE-20-1391

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 European Society of Endocrinology

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Significant inverse correlation between TSH, FT3 and C-reactive protein (CRP) levels with total cortisol (top panels) and IL-6 (bottom panels). Top panels: patients taking steroids or aldosterone antagonists were excluded from the analysis. Mean cortisol levels were not significantly different between patients treated with antiretroviral therapy (n = 25) or not (n = 15), data not shown. Bottom panels: values obtained after administration of tocilizumab were excluded from the analysis.